Korean diagnostics biotech goes Trans-Pacific, agreeing to shell out $1.5B to take US...

cafead

Administrator
Staff member
  • cafead   Jul 08, 2022 at 10:42: AM
via A Korean diagnostics player that made millions of Covid-19 tests in the early stages of the pandemic is now expanding into the US market.

Cincinnati-based Meridian Bioscience put up notice Thursday morning that it’s going to be acquired by SD Biosensor, accompanied by investment firm SJL Partners for $1.53 billion in cash.

article source